Literature DB >> 24766320

Adults face increased asthma risk after infant RSV bronchiolitis and reduced respiratory health-related quality of life after RSV pneumonia.

Katri Backman1, Eija Piippo-Savolainen, Hertta Ollikainen, Heikki Koskela, Matti Korppi.   

Abstract

AIM: To evaluate the association between hospitalisation for respiratory syncytial virus lower respiratory tract infection (RSV LRTI) in infancy and asthma, respiratory health-related quality of life and lung function at 28-31 years of age.
METHODS: In 2010, we carried out a 30-year follow-up on 43 adults admitted to Kuopio University Hospital, Finland, for RSV LRTI, 27 for bronchiolitis and 16 for pneumonia, between 1981 and 1982. Together with 86 population-based controls, they completed the Saint George's Respiratory Questionnaire and underwent prebronchodilator (pre-BD) and post-BD spirometry tests to measure percentage of predicted forced vital capacity (FVC%), percentage of predicted forced expiratory volume in 1 sec (FEV1%) and percentage of predicted FEV1/FVC (FEV1/FVC%).
RESULTS: Both the pre-BD and post-BD FEV1% and FEV1/FVC% were significantly lower in former RSV LRTI patients than in the controls. The bronchiolitis patients had more asthma in adulthood than the controls and pneumonia in infancy was associated with lower St George's Respiratory Questionnaire (SGRQ) scores.
CONCLUSION: Respiratory tract infection LRTI hospitalisation in infancy was associated with an increased risk of permanent obstructive lung function reduction in adulthood. The asthma risk was higher after hospitalisation for bronchiolitis, than in the controls, and respiratory health-related quality of life was lower after hospitalisation for pneumonia. ©2014 Foundation Acta Paediatrica. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Asthma; Bronchiolitis; Lower respiratory tract infection; Lung function; Pneumonia; Respiratory syncytial virus

Mesh:

Year:  2014        PMID: 24766320     DOI: 10.1111/apa.12662

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  15 in total

Review 1.  The role of dendritic cells and monocytes in the maintenance and loss of respiratory tolerance.

Authors:  Cara L Hrusch; Melissa Y Tjota; Anne I Sperling
Journal:  Curr Allergy Asthma Rep       Date:  2015-01       Impact factor: 4.806

2.  Depletion of TAX1BP1 Amplifies Innate Immune Responses during Respiratory Syncytial Virus Infection.

Authors:  Delphyne Descamps; Andressa Peres de Oliveira; Lorène Gonnin; Sarah Madrières; Jenna Fix; Carole Drajac; Quentin Marquant; Edwige Bouguyon; Vincent Pietralunga; Hidekatsu Iha; Armando Morais Ventura; Frédéric Tangy; Pierre-Olivier Vidalain; Jean-François Eléouët; Marie Galloux
Journal:  J Virol       Date:  2021-08-25       Impact factor: 5.103

3.  Interferon response to respiratory syncytial virus by bronchial epithelium from children with asthma is inversely correlated with pulmonary function.

Authors:  Matthew C Altman; Stephen R Reeves; Andrew R Parker; Elizabeth Whalen; Kira M Misura; Kaitlyn A Barrow; Richard G James; Teal S Hallstrand; Steven F Ziegler; Jason S Debley
Journal:  J Allergy Clin Immunol       Date:  2017-10-26       Impact factor: 10.793

4.  A longitudinal study on early hospitalized airway infections and subsequent childhood asthma.

Authors:  Mei-Jy Jeng; Yu-Sheng Lee; Pei-Chen Tsao; Chia-Feng Yang; Wen-Jue Soong
Journal:  PLoS One       Date:  2015-04-28       Impact factor: 3.240

5.  Generation and Characterization of ALX-0171, a Potent Novel Therapeutic Nanobody for the Treatment of Respiratory Syncytial Virus Infection.

Authors:  Laurent Detalle; Thomas Stohr; Concepción Palomo; Pedro A Piedra; Brian E Gilbert; Vicente Mas; Andrena Millar; Ultan F Power; Catelijne Stortelers; Koen Allosery; José A Melero; Erik Depla
Journal:  Antimicrob Agents Chemother       Date:  2015-10-05       Impact factor: 5.191

6.  Genome-Wide Association Study of Polymorphisms Predisposing to Bronchiolitis.

Authors:  Anu Pasanen; Minna K Karjalainen; Louis Bont; Eija Piippo-Savolainen; Marja Ruotsalainen; Emma Goksör; Kuldeep Kumawat; Hennie Hodemaekers; Kirsi Nuolivirta; Tuomas Jartti; Göran Wennergren; Mikko Hallman; Mika Rämet; Matti Korppi
Journal:  Sci Rep       Date:  2017-01-31       Impact factor: 4.379

Review 7.  The Burden and Long-term Respiratory Morbidity Associated with Respiratory Syncytial Virus Infection in Early Childhood.

Authors:  Brigitte Fauroux; Eric A F Simões; Paul A Checchia; Bosco Paes; Josep Figueras-Aloy; Paolo Manzoni; Louis Bont; Xavier Carbonell-Estrany
Journal:  Infect Dis Ther       Date:  2017-03-29

8.  Hyper-Enriched Anti-RSV Immunoglobulins Nasally Administered: A Promising Approach for Respiratory Syncytial Virus Prophylaxis.

Authors:  Emilie Jacque; Claire Chottin; Daphné Laubreton; Michel Nogre; Cécile Ferret; Sandrine de Marcos; Linda Baptista; Carole Drajac; Philippe Mondon; Christophe De Romeuf; Marie-Anne Rameix-Welti; Jean-François Eléouët; Sami Chtourou; Sabine Riffault; Gérald Perret; Delphyne Descamps
Journal:  Front Immunol       Date:  2021-06-07       Impact factor: 7.561

9.  Downregulation of matrix metalloproteinase‑19 induced by respiratory syncytial viral infection affects the interaction between epithelial cells and fibroblasts.

Authors:  Xiuxiu Wu; Huijuan Qi; Yan Yang; Yunhong Yin; Dedong Ma; Hao Li; Yiqing Qu
Journal:  Mol Med Rep       Date:  2015-11-06       Impact factor: 2.952

10.  Association between early bronchiolitis and the development of childhood asthma: a meta-analysis.

Authors:  Guizuo Wang; Dong Han; Zhengdong Jiang; Manxiang Li; Shumei Yang; Lu Liu
Journal:  BMJ Open       Date:  2021-05-28       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.